The Hungarian Centre of Excellence for Molecular Medicine (HCEMM) has been founded in Szeged. The project, with over 15 billion HUF funding, focuses on biomedical research and diagnostics of non-communicable, widespread and common disease, including cardiovascular diseases, cancer and inflammatory diseases, which claim around 30 million victims each year worldwide.
The scientific research will place a strong emphasis on the diagnostics of diseases that are widespread in Hungary, including immunological, metabolic and tumorous diseases, cardiovascular diseases, such as hypertension; rheumatism, eczema, psoriasis, diabetes and cancer. The future centre in Szeged will strongly promote the clinical application of the results of basic research and the development of new therapy methods. Results from this research may provide breakthroughs in molecular diagnostics and also customized therapy.
The HCEMM was established through cooperation of the University of Szeged, the Biological Research Centre, Hungarian Academy of Sciences, Szeged, the University of Debrecen, Semmelweis University and the European Molecular Biology Laboratory. The centre for excellence will enhance the research capacity of each institute and the formation of new scientific relations. Additional common goals include the joint development of infrastructure, joint doctoral training programmes and joint clinical research training programmes.
